Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMS5552 in Type 2 Diabetes Mellitus – Phase II, 12-week RCT
CTR20150656Phase 2Completed
- Sponsor
- Hua Medicine
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dorzagliatin in type 2 diabetes mellitus (T2DM), sponsored by Hua Medicine. Started Oct 2015; status: completed.
02
Drugs
dorzagliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20150656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150656.